MedPath

Comparing Midazolam and Dexmedetomidine as sedative and for decreasing anxiety in general anaesthesia in controlled hypertensive patients undergoing elective surgery

Not yet recruiting
Conditions
Essential (primary) hypertension,
Registration Number
CTRI/2021/07/034904
Lead Sponsor
ABVIMS DR RML HOSPITAL
Brief Summary

This is a randomized competitive study on premedication with  midazolam and Dexmedetomidine on sedation and anxiety in controlled hypertensive patients undergoing elective surgery under general anaesthesia with a  sample size of 100 and place of study is ABVIMS and Dr Rml hospital ,New Delhi ,India.Primary outcome include sedation scoring by RSS and anxiety level by using VAS-A -A

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

1.Age between 20 to 75 years 2.ASA 2.

Exclusion Criteria

1.Renal and hepatic dysfunction 2.cardiovascular diseases 3.uncontrolled hypertensive patients 4.Pregnant or lactating 5.opiod use 6.history of drug sensitivity,seizures,psychiatric disorders 7.patient on beta-blockers.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.sedation scoring by RSS at 5 minutes interval1.sedation scoring by RSS at 5 minutes interval | 2.Anxiety level using VAS-A at 5 minutes interval
2.Anxiety level using VAS-A at 5 minutes interval1.sedation scoring by RSS at 5 minutes interval | 2.Anxiety level using VAS-A at 5 minutes interval
Secondary Outcome Measures
NameTimeMethod
1.Hemodynamic measurements at 5 minutes intervalMean arterial pressure ,systolic blood pressure,diastolic blood pressure

Trial Locations

Locations (1)

ATAL BHIHARI VAJPAYEE INSTITUTE OF MEDICAL SCIENCES AND DR RAM MANOHAR LOHIA HOSPITAL

🇮🇳

Delhi, DELHI, India

ATAL BHIHARI VAJPAYEE INSTITUTE OF MEDICAL SCIENCES AND DR RAM MANOHAR LOHIA HOSPITAL
🇮🇳Delhi, DELHI, India
NITHISHA ROY
Principal investigator
8806835587
nithisharoy11@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.